Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prothrombin Fragments”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableUnknownNCT01626521
What this trial is testing

Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

Who this might be right for
Chronic Obstructive Pulmonary DiseasePulmonary Embolism
Hillel Yaffe Medical Center 20
Not applicableUnknownNCT01078792
What this trial is testing

Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

Who this might be right for
Pulmonary Disease, Chronic ObstructiveDisease ExacerbationPulmonary Embolism+1 more
Hillel Yaffe Medical Center
Testing effectiveness (Phase 2)Study completedNCT02207257
What this trial is testing

Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban

Who this might be right for
Anticoagulation Reversal
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 65
Post-approval studies (Phase 4)Study completedNCT00790387
What this trial is testing

Tirofiban and Enoxaparin in High Risk Coronary Intervention

Who this might be right for
Acute Coronary Syndrome
The Prince Charles Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT07582835
What this trial is testing

Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndromes+3 more
Cardiocentro Ticino 355